South Korea reports third MERS death as alarm grows

South Korea reports third MERS death as alarm grows

By Ju-min Park and Tony Munroe SEOUL (Reuters) – South Korea on Thursday confirmed that a man who died a day earlier had been infected with Middle East Respiratory Syndrome (MERS), the third fatality in a virus outbreak that has caused growing alarm in the country. The 82-year old South Korean, in hospital with asthma and bacterial pneumonia, had shared a room with others infected with MERS and died on

US regulators discuss 'female Viagra'

Advisors to US regulators looked for a third time Thursday at the merits of a drug nicknamed the “female Viagra” because it could help increase women’s sex drive. If the US Food and Drug Administration gives flibanserin the go-ahead, it would be the first drug on the market designed to boost female libido. Flibanserin, which is aimed at pre-menopausal women, also can have significant side effects including nausea, dizziness and

EU drug agency sees no U.S.-like cannabis legalization moves

By Andrei Khalip LISBON (Reuters) – European Union countries are unlikely to legalize marijuana any time soon as some parts of the United States have done recently, EU drug monitoring agency chief Wolfgang Gotz said on Thursday. It also pointed out an increase in the numbers of cannabis-related health emergencies in Europe between 2008 and 2012. Gotz told a briefing arranged to present the European Monitoring Centre for Drugs and

Diabetes pill may lower risk of eye disease in elderly

By Lisa Rapaport (Reuters Health) – Metformin, a pill that lowers blood sugar in people with diabetes, might also reduce their risk of developing glaucoma, an eye disease that can lead to vision loss and blindness, a new study suggests. While the results can’t prove the drug prevents glaucoma, researchers found that diabetics taking higher doses of metformin were less likely to develop the eye disease than those who used